With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.13104-56-8,4′-(4-Methoxyphenyl)-2,2′:6′,2”-terpyridine,as a common compound, the synthetic route is as follows.
General procedure: A mixtureof CuSO4 ¡¤ 5H2O (0.05 mmol, 0.0125 g), Meophtpy (0.1 mmol, 0.0340 g) and NaClO4 (0.1 mmol, 0.0122 g) in 95% EtOH (10 mL) were sealed in a 15 mL Telfon-lined stainless steel container, which was heated to 160C for 48 h. After cooling to room temperature at a rate of 5 K h-1, the green block crystals were obtained in about 55% yield based on Cu. IR (KBr; nu, cm-1): 3566.38 m, 3068.75 m,3014.74 m, 2935.66 m, 2839.22 m, 2015.61w,1869.02 w, 1600.92 v.s, 1575.84 s, 1544.98 s, 1519.91 s,1473.62 v.s, 1433.11 s, 1408.04 s, 1365.60 m,1307.74 m, 1280.73 m, 1246.02 v.s, 1184.29 v.s,1163.08 m, 1089.78 v.s, 1016.49 v.s, 831.47 m,831.32 v.s, 792.74 v.s, 746.45 m, 731.02 m, 688.59 m,657.73 m, 621.08 v.s, 582.50 s, 520.76 m, 472.56 m,455.20 m, 433.98 m, 414.70 m.
13104-56-8, As the paragraph descriping shows that 13104-56-8 is playing an increasingly important role.
Reference£º
Article; Fu; Cheng; Wang; He; Liu; Zhang; Russian Journal of Coordination Chemistry; vol. 43; 8; (2017); p. 547 – 558; Koord. Khim.; vol. 43; 8; (2017); p. 547 – 558,12;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI